| BBB | blood–brain barrier |
| CNS | central nervous system |
| EAE | experimental autoimmune encephalomyelitis |
| IL-1β | interleukin 1β |
| IL-6 | interleukin 6 |
| TNFα | tumor necrosis factor |
| CX3CL1 | chemokine (C-X3- C motif) ligand 1or fractalkine |
| CX3CR1 | chemokine (C-X3-C motif) receptor 1 |
| MCP-1 | monocyte chemoattractant protein 1 |
| CCL2 | chemokine (C-C motif) ligand 2 |
| MIP-1α | macrophage inflammatory protein 1-alpha |
| CCL3 | chemokine (C-C motif) ligand 3 |
| RANTES | regulated on activation, normal T cell expressed and secreted |
| CCL5 | chemokine (C-C motif) ligand 5 |
| TREM2 | triggering receptor expressed on myeloid cells 2 |
| LPS | lipopolysaccharide |
| ApoE | apolipoprotein E |
| MERTK | Mer receptor tyrosine kinase |
| MEGF10 | multiple EGF-like-domains 10 |
| BAI1 | brain-specific angiogenesis inhibitor 1 |
| GFAP | glial fibrillary acidic protein |
| EGF | epidermal growth factor |
| FGF | fibroblast growth factor |
| TGF-β | transforming growth factor β |
| ER | estrogen receptors |
| PR | progesterone receptor |
| AR | androgen receptor |
| PTMs | post-translational modifications |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| MMP9 | metalloproteinase 9 |
| PGE2 | prostaglandin E2 |
| iNOS | nitric oxide synthases |
| SERMs | selective estrogen receptor modulators |
| STEAR | selective tissue estrogenic activity regulator |